You are here

  • Home
  • Archive
  • Volume 27, Issue Suppl 1
  • NP-012 Cost effectiveness analysis and indirect comparison can support the price’ definition of a drug? The case of encorafenib and binimetinib in metastatic melanoma, the pharmacist’s point of view

Article metrics

Article menu

Download PDFPDF

National Poster Prize Winners
NP-012 Cost effectiveness analysis and indirect comparison can support the price’ definition of a drug? The case of encorafenib and binimetinib in metastatic melanoma, the pharmacist’s point of view
Free

 

Online download statistics by month:

Online download statistics by month: March 2020 to October 2024

AbstractFullPdf
Mar 2020805
Apr 20203707
May 2020301
Jun 20201703
Jul 20201204
Aug 2020100
Sep 2020806
Oct 20202507
Nov 2020302
Dec 2020801
Jan 2021402
Feb 2021102
Mar 20211204
May 2021404
Jun 2021101
Jul 2021002
Aug 2021002
Sep 2021004
Oct 20216020
Nov 202114013
Dec 2021806
Jan 2022600
Feb 2022600
Mar 20221602
Apr 2022200
May 2022608
Jun 2022404
Jul 2022900
Aug 2022202
Sep 2022608
Oct 2022403
Nov 2022400
Dec 20221001
Jan 2023704
Feb 20231701
Mar 2023600
Apr 2023603
May 2023002
Jun 2023402
Jul 2023403
Sep 2023202
Oct 2023201
Nov 2023802
Dec 2023600
Jan 2024803
Feb 20242002
Mar 202414020
Apr 2024804
May 2024401
Jun 2024602
Jul 20241003
Aug 2024305
Sep 20241100
Oct 2024403
Total3970187